Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 614-626-2 | CAS number: 685853-81-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation
- Remarks:
- in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- As with all inorganic salts, the significance for toxicity or environmental assessment is the presence of specific ions that will form when in solution or when in biological systems.In the case of Cr III salts, the counter ion will have an effect on solubility and this is itself dependant on the type of media being used and in particular the pH of that media. It is generally accepted that in the case of metal salts, testing with salts that are soluble in the respective test media will ensure maximum exposure of the metal ions. This will include chlorides and nitrates as being more soluble and will indeed have relevance when dissolved in acid media, such as if ingested.Read-across to other chromium III salts is therefore considered valid as long as the exposure in the test system is greater than wold be expected for the substance under review for registration.
Data source
Reference
- Reference Type:
- publication
- Title:
- Sensitization of guinea pigs to chromium salts
- Author:
- Gross, P.R. ; Katz, S.A.; Samitz, M.H.
- Year:
- 1 968
- Bibliographic source:
- J. Investigative Dermatology, 50(5), 424-427
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- Maximised method
- Principles of method if other than guideline:
- The purpose of the study was to examine cross sensitisation between Cr(VI) and Cr(III). The test method was modiifeid to provide a consistently successful level of sensitisation.
- GLP compliance:
- no
- Remarks:
- Study predates GLP
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Existing data; further animal studies not justified
Test material
- Reference substance name:
- Chromic chloride
- IUPAC Name:
- Chromic chloride
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: albino
- Sex:
- not specified
- Details on test animals and environmental conditions:
- TEST ANIMALS- Weight at study initiation: 300-500 g
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal
- Vehicle:
- other: induction: Freund's complete adjuvant, elicitaiton: phsiological saline
- Concentration / amount:
- 0.5 ml of 0.034 M CrCl3 = 5.34 g/l concetration
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challenge
- Route:
- intradermal
- Vehicle:
- other: induction: Freund's complete adjuvant, elicitaiton: phsiological saline
- Concentration / amount:
- 0.1 ml of 0.00042 M Cr Cl3 = 66 mg/l
- Adequacy of challenge:
- other: Based on known effects of Cr 6+
- No. of animals per dose:
- 30
- Details on study design:
- Guinea pigs were sensitised by adminstering three subcutaneous injections of an emulsion containing 0.5 cc Freund's complete adjucant and 0,5 cc 3.4 x 10-2 M CrCl3 into the nape one week apart. Three weeks later, the animals were tested with intradermal injections in clipped or epilated skin. The eliciting dose was 4.2 x 10-4 M CrCl3. Animals sensitised with CrCl3 were also tested with a number of additional trivalent salts, and to conjugates of chromium linked with plasma proteins and skin extract proteins. The concentrations were determined as being the lowest concentrations causing positive effects with Chrome VI compounds.
- Challenge controls:
- The challenge dose produced no reaction in 30 control animals.
Results and discussion
In vivo (non-LLNA)
Results
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 66 mg/l
- No. with + reactions:
- 0
- Total no. in group:
- 30
- Clinical observations:
- No adverse effects
- Remarks on result:
- no indication of skin sensitisation
Any other information on results incl. tables
The eliciting dose produced at 48 hrs a well defined indurated erythematous papule at least 10 mm in diameter.
Ten out of 13 animals developed positive reactions (at least +1). four of these were read as +2. None developed +3 or +4 reactions. Eight out of 10 of these animals also reacted to KCr2O7 (Cr(VI). The differences in the level of reaction were not statistically significant.
Table II Skin test reactions to potassium dichromate and chromic chloride in guinea pigs sensitised to chromic chloride
Guinea pig number | Chromic chloride | Potassium dichromate |
1 | +1 | +1 |
2 | +2 | +1 |
3 | +1 | +2 |
4 | +1 | +1 |
5 | +1 | +1 |
6 | +2 | +2 |
7 | +1 | - |
8 | +2 | +1 |
9 | +1 | +1 |
10 | +2 | - |
Note: (—)= noresponse; (±) =equivocal response, less than 10 mm diameter; (+1) = response of 10 mm diameter; (+2) = response of 15mm diameter; (+3) response of 20 mm diameter; (+4) response of 20 mm diameter with central necrosis.
Similar studies were also carried out with solutions of four other trivalent chromium salts. The highest concentrations which were not irritating to control animals were determined by serial dilution and subsequently used for skin testing. These were: chromic acetate (2.5 x 10-3M), chromic nitrate (9.6 x 10-4M), chromic oxalate (2.5 x10-4M), chromic sulfate (2.4 X 10 M). Three animals sensitized to CrCl3 showed weaker cross-reactions to the same compounds.
TABLE IV Skin test reactions to chromium salts in guinea pigs which had been sensitized to chromic chloride
Guinea pig no | Chromic chloride | Potassium dichromate | Chromic acetate | Chromic nitrate | Chromic sulfate | Chromic oxalate |
1 | +1 | +1 | - | +1 | +1 | ± |
2 | +2 | +1 | +1 | +1 | +1 | ± |
3 | +2 | - | +1 | +2 | +1 | - |
Attempts to sensitize guinea pigs with the above trivalent salts, other than CrC13, were uniformly unsuccessful. Concentrations of 1.7 x 10-2 M to 5 x 10-2 M were used with Freund's complete adjuvant in a schedule identical to that which had been successfully used for potassium dichromate and chromic chloride.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- Guinea pigs were sensitised to chromic chloride in a procedure designed to mazimise the sensitisation response. attempts to sensitise guinea pigs to other chromium (III) salts (chromic acetate, chomic nitrate, chromic oxalate and chromic sulfate were uniformly unsuccessful.
- Executive summary:
Thirteen guinea-pigs were given chromium chloride hexahydrate by three subcutaneous injections in the nape 1 week apart. The sensitizing injections contained 0.5 ml of FCA with 0.5 ml of 3.4 × 10−2 M chromium chloride. Three weeks later, the animals were tested with an intradermal injection into clipped or epilated skin. The eliciting dose was 0.1 ml of 4.2 × 10−4 M chromium chloride. After 48 h, this produced moderate positive responses in 10 of the 13 animals, whereas the control animals (injected only with FCA) showed no reactions.
Of the 10 guinea-pigs sensitized to chromium chloride, 3 elicited weaker cross-reactions after intradermal injection of chromium acetate, chromium nitrate and chromium sulfate. Chromium oxalate did not elicit significant reactions. Using the same study method, the authors also attempted to sensitize guinea-pigs with chromium acetate, chromium nitrate, chromium sulfate and chromium oxalate, but without success.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.